KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Goodwill (2017 - 2025)

Novartis Ag (NVS) has disclosed Goodwill for 9 consecutive years, with $25.6 billion as the latest value for Q4 2025.

  • Quarterly Goodwill rose 3.28% to $25.6 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $25.6 billion through Dec 2025, up 3.28% year-over-year, with the annual reading at $25.6 billion for FY2025, 3.28% up from the prior year.
  • Goodwill hit $25.6 billion in Q4 2025 for Novartis Ag, up from $24.8 billion in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $29.6 billion in Q4 2021 to a low of $23.3 billion in Q4 2023.
  • Historically, Goodwill has averaged $26.5 billion across 5 years, with a median of $25.6 billion in 2025.
  • Biggest five-year swings in Goodwill: dropped 20.34% in 2023 and later rose 6.06% in 2024.
  • Year by year, Goodwill stood at $29.6 billion in 2021, then dropped by 0.99% to $29.3 billion in 2022, then fell by 20.34% to $23.3 billion in 2023, then increased by 6.06% to $24.8 billion in 2024, then grew by 3.28% to $25.6 billion in 2025.
  • Business Quant data shows Goodwill for NVS at $25.6 billion in Q4 2025, $24.8 billion in Q4 2024, and $23.3 billion in Q4 2023.